VSTM - Verastem, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Needham,
United States
Type: Equity
VSTM price evolution
VSTM
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $83.61 | $81.56 | $78.15 | |
| Short term investments | $28.81 | $59.22 | ||
| Net receivables | $0.2 | $10.82 | $0.23 | |
| Inventory | ||||
| Total current assets | $120.66 | $99.65 | $117.67 | $143.68 |
| Long term investments | ||||
| Property, plant & equipment | $0.66 | $0.86 | $1.05 | $1.21 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $6.1 | $5.87 | $6.04 | |
| Total investments | $28.81 | $59.22 | ||
| Total assets | $126.38 | $105.75 | $123.54 | $149.72 |
| Current liabilities | ||||
| Accounts payable | $4.44 | $6.68 | $7.45 | $7.18 |
| Deferred revenue | ||||
| Short long term debt | $6.47 | $1.89 | $0.94 | |
| Total current liabilities | $37.37 | $30.35 | $26.73 | $26.38 |
| Long term debt | $30.65 | $35.39 | $40.39 | $40.62 |
| Total noncurrent liabilities | $35.39 | $50.59 | $44.8 | |
| Total debt | $41.86 | $42.28 | $41.56 | |
| Total liabilities | $94.16 | $65.74 | $77.32 | $71.19 |
| Shareholders' equity | ||||
| Retained earnings | -$890.98 | -$867.01 | -$858.75 | -$824.89 |
| Other shareholder equity | -$0 | $0.01 | ||
| Total shareholder equity | $18.85 | $25.06 | $57.37 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $78.15 | $75.17 | $21.49 | $68.02 |
| Short term investments | $59.22 | $12.96 | $79 | $73.44 |
| Net receivables | $0.03 | $0.52 | $0.24 | |
| Inventory | ||||
| Total current assets | $143.68 | $92.87 | $105.74 | $144.94 |
| Long term investments | $6 | |||
| Property, plant & equipment | $1.21 | $1.88 | $2.51 | $3.14 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $6.04 | $2.18 | $2.92 | $9.41 |
| Total investments | $59.22 | $12.96 | $79 | $79.44 |
| Total assets | $149.72 | $95.05 | $108.66 | $154.35 |
| Current liabilities | ||||
| Accounts payable | $7.18 | $4.9 | $2.3 | $1.88 |
| Deferred revenue | ||||
| Short long term debt | $0.94 | $1.07 | $0.67 | $0.56 |
| Total current liabilities | $26.38 | $21.66 | $18.59 | $17.09 |
| Long term debt | $40.62 | $24.53 | $2.51 | $21.98 |
| Total noncurrent liabilities | $44.8 | $26 | $2.51 | $21.98 |
| Total debt | $41.56 | $27.07 | $3.18 | $22.54 |
| Total liabilities | $71.19 | $47.66 | $21.1 | $39.08 |
| Shareholders' equity | ||||
| Retained earnings | -$824.89 | -$737.52 | -$663.71 | -$592.51 |
| Other shareholder equity | $0.01 | $0.03 | $0.05 | |
| Total shareholder equity | $57.37 | $47.39 | $87.56 | $115.27 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10 | |||
| Cost of revenue | ||||
| Gross Profit | $10 | |||
| Operating activities | ||||
| Research & development | $18.06 | $17.71 | $22.5 | |
| Selling, general & administrative | $10.21 | $10.35 | $8.64 | |
| Total operating expenses | $28.3 | $28.09 | $31.14 | |
| Operating income | -$18.3 | -$28.09 | -$31.14 | |
| Income from continuing operations | ||||
| EBIT | -$7.12 | -$32.73 | -$26.25 | |
| Income tax expense | ||||
| Interest expense | $1.14 | $1.13 | $1.12 | |
| Net income | ||||
| Net income | -$8.26 | -$33.86 | -$27.37 | |
| Income (for common shares) | -$8.26 | -$33.86 | -$27.37 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.6 | $2.05 | $88.52 | |
| Cost of revenue | $33.74 | |||
| Gross Profit | $2.6 | $2.05 | $54.77 | |
| Operating activities | ||||
| Research & development | $61.36 | $50.56 | $39.35 | $41.38 |
| Selling, general & administrative | $30.73 | $24.98 | $24.11 | $62.76 |
| Total operating expenses | $92.08 | $75.53 | $63.46 | $104.13 |
| Operating income | -$92.08 | -$72.94 | -$61.41 | -$49.36 |
| Income from continuing operations | ||||
| EBIT | -$83.23 | -$71.67 | -$61.23 | -$51.74 |
| Income tax expense | $0.19 | |||
| Interest expense | $4.14 | $2.14 | $9.97 | $15.79 |
| Net income | ||||
| Net income | -$87.37 | -$73.81 | -$71.2 | -$67.73 |
| Income (for common shares) | -$87.37 | -$73.81 | -$71.2 | -$67.73 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$8.26 | -$33.86 | -$27.37 | |
| Operating activities | ||||
| Depreciation | -$0.04 | -$0.04 | -$0.04 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.91 | $1.48 | $1.6 | |
| Total cash flows from operations | -$27.57 | -$28.31 | -$29.68 | |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.02 | ||
| Investments | $29 | $31 | $12.44 | |
| Total cash flows from investing | $59.97 | $28.99 | $30.98 | $12.44 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.14 | $0.09 | ||
| Net borrowings | -$0.39 | $0.76 | -$0.45 | |
| Total cash flows from financing | $54.04 | -$0.41 | $0.85 | -$0.45 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $34.34 | $1.02 | $3.52 | -$17.69 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$87.37 | -$73.81 | -$71.2 | -$67.73 |
| Operating activities | ||||
| Depreciation | -$0.11 | -$0.04 | $0.07 | $0.46 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.86 | $6.05 | $7.71 | $8.12 |
| Total cash flows from operations | -$86.46 | -$63.67 | -$53.5 | -$33.51 |
| Investing activities | ||||
| Capital expenditures | -$0.2 | -$0.03 | ||
| Investments | -$44.45 | $66.19 | $0.28 | -$47.33 |
| Total cash flows from investing | -$44.45 | $66.19 | $0.09 | -$47.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $91.48 | $27.64 | $7.81 | $109.04 |
| Net borrowings | $14.62 | $24.15 | -$39.13 | |
| Total cash flows from financing | $134.19 | $51.78 | $6.88 | $69.63 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $3.29 | $54.3 | -$46.53 | -$11.24 |
News
Fundamentals
| Market cap | $228.29M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 40.26M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.24 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.23 |
| Quick ratio | N/A |